ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0234

Use of Corneal Confocal Microscopy to Assess Small Fiber Neuropathy in Patients with Sarcoidosis

Philip Bucur1, Kelly Gwathmey2, Huzaefah Syed2, Aamer Syed2, Thomas Iden3, Neha Gupta2, Jessica McLaughlin2, Jordana Kron2, Ryan Canissario2, Shanshan Chen1, Hoda Gad4, Rayaz Malik4, Sai Patel2 and Vaishali Patel2, 1VCU Health, Richmond, VA, 2Virginia Commonwealth University Medical Center, Richmond, VA, 3Virginia Commonwealth University Medical Center, Richmond, 4Weill Cornell Medicine-Qatar, Doha, Qatar

Meeting: ACR Convergence 2025

Keywords: neurology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0233–0279) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Small fiber neuropathy (SFN) is a common complication of sarcoidosis, affecting about one third of patients. The current gold standard for diagnosis combines patient history and a skin biopsy to quantify small nerve fibers. Corneal confocal microscopy (CCM) is now being used with more frequency to evaluate nerve fibers in the cornea, specifically in diabetic neuropathy. However, further research is needed to validate the role of CCM in sarcoidosis. Our study focused on CCM and how it can be utilized as an accurate, non-invasive diagnostic tool for SFN in patients with sarcoidosis.

Methods: This study is a subset analysis of a larger study to better characterize SFN in sarcoidosis. A total of 12 patients with sarcoidosis who completed CCM analysis were included in the study. We categorized sarcoidosis patients into two groups: those with a physician impression of neuropathy (PIN) and those without a physician impression of neuropathy (non-PIN). A third group, healthy age-matched controls without sarcoidosis from a database, were added for comparison. CCM was performed to determine corneal nerve fiber density, length and tortuosity and corneal nerve branch density.

Results: CCM data was collected on 12 patients with sarcoidosis, 8 of who had PIN and 4 of who had non-PIN. The mean age of patients in the PIN group was 52.8 years with 87.5% females. The non-PIN group averaged 47.25 years old with 50% females. The healthy control group had a mean age of 51.3 years with no data on sex. One-way ANOVA analysis revealed a difference in corneal nerve fiber density (CNFD) approaching significance (p = 0.05) between the three groups. Post-hoc comparison using two-sample t-test to assess for between-group differences revealed a statistically significant difference in CNFD (p = 0.03), and a difference in corneal nerve branch density approaching statistical significance (p = 0.05) between age-matched controls and PIN patients. However, there was not a difference in corneal nerve fiber length or corneal nerve fiber tortuosity between the two groups. There was no statistical difference noted in any of the measures between healthy controls and the non-PIN group or when comparing the PIN and the non-PIN groups.

Conclusion: CCM is a non-invasive method to capture images of small nerve fibers as a marker for SFN. Primarily used in diabetic neuropathy, our study findings indicate CCM can provide diagnostic data in patients with sarcoidosis and features of SFN, especially when analyzing CNFD. Interestingly, though not statistically significant, non-PIN patients trended toward having low corneal nerve fiber and branch densities, similar to PIN patients. Due to the low number of patients in our study, further research will be needed to validate the use of CCM as a screening tool for SFN in sarcoidosis patients.

Supporting image 1Table 1. One-way ANOVA test analyzing group differences in corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), and corneal nerve fiber tortuosity (CNFT) among three groups: health controls (HC), patients without a clinical impression of peripheral neuropathy (non-PIN), and patients with a clinical impression of neuropathy (PIN). The difference in CNFD is approaching statistical significance between the groups (p = 0.05).

Supporting image 2Figure 1. Corneal nerve fiber densities (CNFD) among healthy controls (HC), patients without a clinical impression of peripheral neuropathy (non-PIN), and patients with a clinical impression of neuropathy (PIN). A statistical difference was noted between healthy controls and PIN groups (p= 0.03).

Supporting image 3Figure 2. Corneal nerve branch densities (CNBD) among healthy controls (HC), patients without a clinical impression of peripheral neuropathy (non-PIN), and patients with a clinical impression of neuropathy (PIN). Though no statistically significant difference was found among the groups, there was a trend towards significance between HC and PIN groups (p = 0.05).


Disclosures: P. Bucur: None; K. Gwathmey: None; H. Syed: None; A. Syed: None; T. Iden: None; N. Gupta: None; J. McLaughlin: None; J. Kron: None; R. Canissario: None; S. Chen: None; H. Gad: None; R. Malik: None; S. Patel: None; V. Patel: None.

To cite this abstract in AMA style:

Bucur P, Gwathmey K, Syed H, Syed A, Iden T, Gupta N, McLaughlin J, Kron J, Canissario R, Chen S, Gad H, Malik R, Patel S, Patel V. Use of Corneal Confocal Microscopy to Assess Small Fiber Neuropathy in Patients with Sarcoidosis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/use-of-corneal-confocal-microscopy-to-assess-small-fiber-neuropathy-in-patients-with-sarcoidosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-corneal-confocal-microscopy-to-assess-small-fiber-neuropathy-in-patients-with-sarcoidosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology